Genetic and pharmacological inhibition of FGFR1 and PLK1 synergizes to enhance anti‐proliferative effects and drive apoptosis in KRAS‐mutant lung and pancreatic cancer cells. Here, FGFR1 is linked to familial pancreatic carcinoma.